Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
34.0%
% of FTXH's 51 holdings also in PJP
68.0%
% of PJP's 25 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 7.3% | 5.5% | 5.5% |
|
PFIZER INC | 6.7% | 5.0% | 5.0% |
|
ABBVIE INC | 6.6% | 4.9% | 4.9% |
|
MERCK & CO. INC. | 6.4% | 4.8% | 4.8% |
|
BRISTOL-MYERS SQUIBB CO | 8.8% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PJP
|
BRISTOL-MYERS SQUIBB CO | 4.8% |
|
CARDINAL HEALTH INC | 4.1% |
|
ZOETIS INC | 3.7% |
|
ORGANON & CO. | 2.5% |
|
CHARLES RIVER LABORATORIES | 2.4% |
|
ELANCO ANIMAL HEALTH, INC. | 1.9% |
|
JOHNSON & JOHNSON | 1.8% |
|
MEDPACE HOLDINGS, INC. | 1.7% |
|
PFIZER INC | 1.7% |
|
ABBVIE INC | 1.7% |
FTXH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -6.0% |
|
CORCEPT THERAPEUTICS INC | -4.3% |
|
PACIRA PHARMACEUTICALS INC | -3.9% |
|
LIGAND PHARMACEUTICALS-CL B | -3.6% |
|
SUPERNUS PHARMACEUTICALS INC | -3.5% |
|
INNOVIVA, INC. | -3.4% |
|
AMPHASTAR PHARMACEUTICALS INC | -3.2% |
|
BIOSANTE PHARMACEUTICALS INC | -3.1% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.9% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.9% |